chr13-48411623-T-G
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_001162498.3(LPAR6):āc.801A>Cā(p.Ala267=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00239 in 1,612,216 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Genomes: š 0.0014 ( 1 hom., cov: 32)
Exomes š: 0.0025 ( 2 hom. )
Consequence
LPAR6
NM_001162498.3 synonymous
NM_001162498.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.83
Genes affected
LPAR6 (HGNC:15520): (lysophosphatidic acid receptor 6) The protein encoded by this gene belongs to the family of G-protein coupled receptors, that are preferentially activated by adenosine and uridine nucleotides. This gene aligns with an internal intron of the retinoblastoma susceptibility gene in the reverse orientation. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2009]
RB1 (HGNC:9884): (RB transcriptional corepressor 1) The protein encoded by this gene is a negative regulator of the cell cycle and was the first tumor suppressor gene found. The encoded protein also stabilizes constitutive heterochromatin to maintain the overall chromatin structure. The active, hypophosphorylated form of the protein binds transcription factor E2F1. Defects in this gene are a cause of childhood cancer retinoblastoma (RB), bladder cancer, and osteogenic sarcoma. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 13-48411623-T-G is Benign according to our data. Variant chr13-48411623-T-G is described in ClinVar as [Likely_benign]. Clinvar id is 780057.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.84 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00141 (214/152294) while in subpopulation NFE AF= 0.00251 (171/68008). AF 95% confidence interval is 0.00221. There are 1 homozygotes in gnomad4. There are 88 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 2 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
LPAR6 | NM_001162498.3 | c.801A>C | p.Ala267= | synonymous_variant | 1/1 | ENST00000620633.5 | |
RB1 | NM_000321.3 | c.1695+30180T>G | intron_variant | ENST00000267163.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
LPAR6 | ENST00000620633.5 | c.801A>C | p.Ala267= | synonymous_variant | 1/1 | 5 | NM_001162498.3 | P1 | |
RB1 | ENST00000267163.6 | c.1695+30180T>G | intron_variant | 1 | NM_000321.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00140 AC: 213AN: 152176Hom.: 1 Cov.: 32
GnomAD3 genomes
AF:
AC:
213
AN:
152176
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00138 AC: 344AN: 250116Hom.: 1 AF XY: 0.00149 AC XY: 201AN XY: 135282
GnomAD3 exomes
AF:
AC:
344
AN:
250116
Hom.:
AF XY:
AC XY:
201
AN XY:
135282
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00250 AC: 3647AN: 1459922Hom.: 2 Cov.: 31 AF XY: 0.00248 AC XY: 1799AN XY: 726396
GnomAD4 exome
AF:
AC:
3647
AN:
1459922
Hom.:
Cov.:
31
AF XY:
AC XY:
1799
AN XY:
726396
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00141 AC: 214AN: 152294Hom.: 1 Cov.: 32 AF XY: 0.00118 AC XY: 88AN XY: 74476
GnomAD4 genome
AF:
AC:
214
AN:
152294
Hom.:
Cov.:
32
AF XY:
AC XY:
88
AN XY:
74476
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 27, 2023 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jul 01, 2022 | LPAR6: BP4, BP7 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at